The Present and Future
Cardiovascular Medicine and Society
Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19

https://doi.org/10.1016/j.jacc.2021.06.001Get rights and content
Under an Elsevier user license
open archive

Key Words

cerebral
COVID-19
sinus
thrombosis
vaccine

Abbreviations and Acronyms

CDC
Centers for Disease Control and Prevention
COVID-19
coronavirus disease-2019
CVST
cerebral venous sinus thrombosis
J&J
Johnson & Johnson
MHRA
Medicines and Healthcare Products Regulatory Agency
SARS-CoV-2
severe acute respiratory syndrome-coronavirus-2

Cited by (0)

The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.